Results: Breast cancer (BC) with high NR2F1 expression, enriched TGFβ signaling, multiple metastases, and stem cell- related pathways.
The authors choose chemotherapy as a treatment option to compare it with NR2F1 levels. It would be interesting to see, how NR2F1 levels would change with endocrine treatment and/or endocrine resistance.